Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patientsD Berd, H C Maguire, P McCue, et al.
Cancer Research|May 15, 1991
Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastasesD Berd, G Murphy, H C Maguire, et al.
Cancer|January 5, 2000
Paclitaxel and tamoxifen: An active regimen for patients with metastatic melanomaF E Nathan, D Berd, T Sato, et al.
Journal of the National Cancer Institute|November 1, 1979
Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agentsR E Bellet, V Danna, M J Mastrangelo, et al.
Medical and Pediatric Oncology|January 1, 1978
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanomaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Seminars in Oncology|February 1, 1996
Detection of specific genetic alterations in cancer cellsK Huebner, M Ohta, J Lubinski, et al.
Chest|July 1, 1989
Flow cytometric evaluation of bronchoscopic washings and lavage fluid for DNA aneuploidy as an adjunct in the diagnosis of lung cancer and tumors metastatic to the lungE B Yoss, D Berd, J R Cohn, et al.
International Journal of Cancer|February 20, 1992
Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trialsE F McClay, M J Mastrangelo, D Berd, et al.
Seminars in Oncology|February 1, 1996
Gene therapy for human cancer: an essay for cliniciansM J Mastrangelo, D Berd, F E Nathan, et al.
Cancer Treatment Reports|December 1, 1978
Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosoureaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Pageof 6